LISHA KALLACHERIL: Open Payments
NPI 1346726296 · FLEMINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,831 in 103 payments from 27 companies in 2025. Trend: 2023 $1,397 · 2024 $1,977 · 2025 $1,831
Food & beverage: $1,827Education: $4
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 15 | $244 |
| Novo Nordisk Inc | 15 | $203 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $196 |
| Corcept Therapeutics | 9 | $142 |
| Dexcom, Inc. | 6 | $135 |
| Radius Health, Inc. | 5 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $94 |
| Xeris Pharmaceuticals, Inc. | 5 | $78 |
| SANOFI-AVENTIS U.S. LLC | 4 | $71 |
| Medtronic, Inc. | 3 | $69 |
Products named: JARDIANCE, Kerendia, Korlym, Dexcom G6 Transmitter, MOUNJARO, Tymlos, Wegovy, TZIELD.
Industry payments across NJ — which companies pay providers there.
